Clinical Trials for Advanced Non Small Cell Lung Cancer

Find clinical trials for advanced non small cell lung cancer. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer

NCT ID: NCT05777603

This clinical trial is exploring a new treatment approach for advanced non-small cell lung cancer (NSCLC), which is a type of lung cancer that can be difficult to treat. The study is looking at whe...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States

A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer

NCT ID: NCT05318573

This clinical trial is studying a new treatment combination for patients with advanced urothelial cancer or non-small cell lung cancer (NSCLC). The treatment involves two drugs: FF-10832, which is ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Charleston, South Carolina, United States, Sioux Falls, South Dakota, United States +22 more

Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated

NCT ID: NCT06908993

This clinical trial is studying a medication called tepotinib to see if it is more effective than standard treatments for patients with advanced non-small cell lung cancer (NSCLC) that has a specif...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Lyon, , France, Nice, , France +27 more

Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients with NSCLC

NCT ID: NCT04886401

The PREDICTION study is looking at how to better understand which patients with advanced non-small cell lung cancer (NSCLC) will respond well to a treatment called pembrolizumab, a type of immunoth...

Recruiting

Type: observational Locations: Brest, , France

Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG

NCT ID: NCT06107374

This clinical trial is studying how well a special imaging technique called [18F]-FARAG PET can help doctors understand how patients with advanced non-small cell lung cancer (NSCLC) respond to a ty...

Recruiting

Phase: PHASE2 Type: interventional Locations: Iowa City, Iowa, United States

Lifei Xiaoji Wan in Treatment of Advanced NSCLC

NCT ID: NCT06406166

This clinical trial is studying a treatment called Lifei Xiaoji Wan for people with advanced non-small cell lung cancer (NSCLC). The goal is to see how well this treatment works and to gather stron...

Recruiting

Phase: NA Type: interventional Locations: Zhengzhou, Henan, China

Sintilimab With Pemigatinib in Patients With PD-L1-positive and FGFR Mutated Advanced Non-small Cell Lung Cancer

NCT ID: NCT05004974

This clinical trial is studying a combination of two medications, Sintilimab and Pemigatinib, to treat patients with advanced non-small cell lung cancer (NSCLC) that is both PD-L1-positive and has ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Yiwu, Zhejiang, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions